Interacting Drugs |
Bendamustine vs CYP1A2 Inducers (Strong) |
Security Level |
 |
Mechanism |
CYP1A2 Inducers (Strong): May decrease the serum concentration of Bendamustine. Concentrations of active metabolites may be increased. |
Management |
Monitor therapy |
Bendamustine vs CYP1A2 Inducers (Strong)
Post Review about Bendamustine vs CYP1A2 Inducers (Strong) Click here to cancel reply.
Other Interactions of Bendamustine
Other Interactions of CYP1A2 Inducers (Strong)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.